Skip to main content

Animations

MJFF Publications

3581 - 3590 of 8684 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2009
  • 2022
  • Summary Details
    OPEN
    Title: Structure of LRRK1 and mechanisms of autoinhibition and activation
    Journal Name: Nature Structural & Molecular Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41594-023-01109-1
    Citation Count: 7
  • Summary Details
    OPEN
    Title: escheR: unified multi-dimensional visualizations with Gestalt principles
    Journal Name: Bioinformatics Advances
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/bioadv/vbad179
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Anionic nanoplastic contaminants promote Parkinson’s disease–associated α-synuclein aggregation
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adi8716
    Citation Count: 106
  • Summary Details
    OPEN
    Title: Parkinson’s VPS35[D620N] mutation induces LRRK2-mediated lysosomal association of RILPL1 and TMEM55B
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adj1205
    Citation Count: 19
  • Summary Details
    OPEN
    Title: Inhibition of Parkinson’s disease–related LRRK2 by type I and type II kinase inhibitors: Activity and structures
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc, cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.adk6191
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2
    Journal Name: Science
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/science.adi9926
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Gut mucosal cells transfer α-synuclein to the vagus nerve
    Journal Name: JCI Insight
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1172/jci.insight.172192
    Citation Count: 22
  • Summary Details
    OPEN
    Title: Adaptor protein-3 produces synaptic vesicles that release phasic dopamine
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1073/pnas.2309843120
    Citation Count: 11
  • Summary Details
    OPEN
    Title: Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson’s disease models
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1242/dmm.004267
    Citation Count: 178
  • Summary Details
    OPEN
    Title: ePosters
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ene.15466
    Citation Count: 12
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.